Key sectors
The Medicines Discovery Catapult is a UK-based centre focused on advancing drug discovery by providing specialized expertise, cutting-edge technologies, and collaborative opportunities for researchers and biotech companies. Dedicated to accelerating the journey from scientific research to patient-ready medicines, the Catapult supports the development of innovative treatments for complex diseases. Through its facilities and services, which include data analysis, lab-based assays, and access to advanced imaging, the Catapult addresses key challenges in the drug discovery process, helping to reduce time, cost, and risk in bringing new therapies to market. Working closely with academia, the pharmaceutical industry, and other stakeholders, the Catapult fosters a collaborative ecosystem aimed at driving medical innovation and improving patient outcomes (“Medicines Discovery Catapult”). This commitment to efficient and effective drug discovery aligns with the UK’s leadership in life sciences and its goal of delivering impactful healthcare solutions.